Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study

July 23, 2020 updated by: Dina mounir elkady, Cairo University

Oral Manifestations of COVID-19: a Multicentre Observational Study

online questionnaire will be distributed in different country to detect the oral change in patient diagnosed with COVID-19

Study Overview

Status

Unknown

Conditions

Detailed Description

an online survey will be performed through google form. Investigators in different country will share the questionnaire with patient diagnosed positive COVID-19.

data collected will be statically analyse to detect the oral picture of the virus.

Study Type

Observational

Enrollment (Anticipated)

50

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patient with no previous serious illness - from different country

Description

Inclusion Criteria:

  • positive COVID-19

Exclusion Criteria:

  • children
  • patient not confirmed by swab

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
positive COVID-19
patient diagnosed by nasopharyngeal positive COVID-19

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oral ulcer
Time Frame: through study completion, an average of 1 month
number of patient with oral ulcer
through study completion, an average of 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hyposalivation
Time Frame: through study completion, an average of 1 month
change in salivary flow
through study completion, an average of 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 15, 2020

Primary Completion (Anticipated)

November 15, 2020

Study Completion (Anticipated)

December 15, 2020

Study Registration Dates

First Submitted

July 21, 2020

First Submitted That Met QC Criteria

July 23, 2020

First Posted (Actual)

July 27, 2020

Study Record Updates

Last Update Posted (Actual)

July 27, 2020

Last Update Submitted That Met QC Criteria

July 23, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 8791

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

data will be on a private mail , no access will be provided except for principal investigator

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe